Milestone Pharmaceuticals Inc. (34)

Browse by Contract Category

Contracts

Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2022)
Employment Agreement, dated February 15, 2022 between David Bharucha, M.D., Ph.D. and Milestone Pharmaceuticals USA, Inc (Filed With SEC on February 16, 2022)
License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021 (Filed With SEC on August 11, 2021)
Form of Pre-Funded Warrants to Purchase Common Shares (Filed With SEC on August 11, 2021)
The Non-employee Director Compensation Policy, as amended (Filed With SEC on May 17, 2021)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 29, 2021)
The Non-employee Director Compensation Policy, as amended (Filed With SEC on November 13, 2020)
Form of Pre-Funded Warrant (Filed With SEC on October 26, 2020)
Underwriting Agreement, dated October 22, 2020, by and among the Company, Jefferies LLC and Piper Sandler & Co (Filed With SEC on October 26, 2020)
Open Market Sale AgreementSM, dated July 29, 2020, by and between Milestone Pharmaceuticals Inc. and Jefferies LLC (Filed With SEC on July 29, 2020)
Securities Purchase Agreement dated July 22, 2020 (Filed With SEC on July 23, 2020)
Form of Pre-Funded Warrant to Purchase Common Shares (Filed With SEC on July 23, 2020)
Amending Agreement, dated June 4, 2020, between the Company and Francis Plat (Filed With SEC on June 9, 2020)
First Amendment to Employment Agreement, dated June 4, 2020, between the Company and Amit Hasija (Filed With SEC on June 9, 2020)
First Amendment to Amended and Restated Employment Agreement, dated June 4, 2020, between the Company and Joseph Oliveto (Filed With SEC on June 9, 2020)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 6, 2020)
Employment Agreement, dated September 9, 2019, between the Company and Amit Hasija (Filed With SEC on September 10, 2019)
Form of Common Share Certificate of the Registrant (Filed With SEC on April 29, 2019)
Employment Agreement between Timothy L. Maness and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
Amended and Restated Employment Agreement between Joseph Oliveto and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
Amended and Restated Employment Agreement between Philippe Douville and Milestone Pharmaceuticals Inc (Filed With SEC on April 29, 2019)
Amended and Restated Employment Agreement between Francis Plat and Milestone Pharmaceuticals Inc (Filed With SEC on April 29, 2019)
Amended and Restated Employment Agreement between Lorenz Muller and Milestone Pharmaceuticals USA, Inc (Filed With SEC on April 29, 2019)
Form of Underwriting Agreement (Filed With SEC on April 29, 2019)
Form of 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
Form of Indemnity Agreement (Filed With SEC on April 12, 2019)
Third Amended and Restated Stock Option Plan (Filed With SEC on April 12, 2019)
Third Amended and Restated Registration Rights Agreement, by and among the Registrant and certain of its shareholders, dated October 15, 2018 (Filed With SEC on April 12, 2019)
Form of United States Stock Option Grant Notice and Stock Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
Form of United States Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
Form of Canadian Stock Option Grant Notice and Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
Form of Canadian Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan (Filed With SEC on April 12, 2019)
2019 Employee Stock Purchase Plan (Filed With SEC on April 12, 2019)
Form of Award and Grant Notices under the Third Amended and Restated Stock Option Plan (Filed With SEC on April 12, 2019)